48,830
edits
Difference between revisions of "Testosterone"
Jump to navigation
Jump to search
no edit summary
(create) |
|||
| Line 3: | Line 3: | ||
==General== | ==General== | ||
*Driver of [[prostate cancer]]. | *Driver of [[prostate cancer]]. | ||
*Testosterone target <0.7 nmol/L.<ref>{{Cite journal | last1 = Shayegan | first1 = B. | last2 = Pouliot | first2 = F. | last3 = So | first3 = A. | last4 = Fernandes | first4 = J. | last5 = Macri | first5 = J. | title = Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians. | journal = Can Urol Assoc J | volume = 11 | issue = 6 | pages = 204-209 | month = Jun | year = 2017 | doi = 10.5489/cuaj.4539 | PMID = 28652880 }}</ref> | *Testosterone (chemical castration) target: <0.7 nmol/L.<ref>{{Cite journal | last1 = Shayegan | first1 = B. | last2 = Pouliot | first2 = F. | last3 = So | first3 = A. | last4 = Fernandes | first4 = J. | last5 = Macri | first5 = J. | title = Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians. | journal = Can Urol Assoc J | volume = 11 | issue = 6 | pages = 204-209 | month = Jun | year = 2017 | doi = 10.5489/cuaj.4539 | PMID = 28652880 }}</ref> | ||
==References== | ==References== | ||